Is Regenerative Medicine the Future of Aesthetic Treatment?
Or Just the Latest Trend?
The honest answer is both and understanding the difference is the most clinically useful thing a patient can know before booking any treatment marketed under this label.
Written by Dr Peter Forrester, Medical Director of The Cosmetic Doctors Company in Surrey UK. Dr Forrester has practised aesthetic medicine for over 25 years and is regarded as an expert in this field.
What is regenerative medicine in aesthetic practice?
Regenerative medicine refers to treatments that stimulate the body's own biological repair and renewal processes, rather than adding a substance that temporarily corrects a concern. In aesthetic medicine the term has become an umbrella for polynucleotides, platelet-rich plasma, exosomes, growth factors, stem cell preparations, and certain biostimulatory injectables such as Sculptra and Profhilo.
The concept is genuinely exciting. Treatments that harness the body's own capacity for self-repair represent a philosophically different and potentially more durable approach than conventional fillers or botulinum toxin. Whether that promise is being delivered consistently across the full range of treatments marketed under this banner is a considerably more complicated question.
Which regenerative treatments have the strongest evidence?
Injectable polynucleotides have a well-characterised mechanism of action involving fibroblast stimulation and tissue repair. The clinical evidence for improvements in skin quality, hydration, and luminosity is real and accumulating. We have written about them in detail elsewhere, our honest assessment is that the injectable evidence is encouraging and the treatment deserves serious clinical consideration in the right patient.
Sculptra and Profhilo represent the most mature and best-evidenced corner of regenerative aesthetic medicine. Both stimulate the body's own collagen and elastin production through well-characterised mechanisms, with clinical evidence spanning years rather than months. These are established treatments with robust evidence behind them.
Platelet-rich plasma has a legitimate biological rationale — concentrating the patient's own growth factors and delivering them to target tissue is a sound concept. The evidence for PRP in hair loss is credible. The skin rejuvenation evidence is thinner and more variable, partly because preparation methods are extremely inconsistent between clinics.
Where has the marketing outrun the evidence?
Topical exosomes are perhaps the most prominent current example of a treatment where the gap between biological concept and clinical evidence is considerable. The biology is fascinating — exosomes are nanoscale vesicles that carry growth factors and signalling molecules between cells.
Whether topically applied exosomes penetrate the skin barrier in sufficient quantities to produce a meaningful biological effect, and whether they remain active after the manufacturing and formulation process, are questions the literature has not yet answered satisfactorily.
Stem cell preparations occupy an even more speculative space. Plant stem cells are biologically irrelevant to human skin. Human stem cell extracts face fundamental questions about whether biologically active material survives formulation in a form capable of producing the claimed effects. The marketing is considerably more developed than the evidence.
How do you tell the difference between genuine regenerative medicine and marketing?
The label regenerative medicine tells you very little about whether a specific treatment works. The questions that do distinguish credible treatments from overhyped ones are straightforward: who funded the research, what did the methodology actually show, does the claimed mechanism correspond to a plausible biological reality, and has the result been independently replicated?
These are the questions we outlined in our Evidence Problem blog post and they apply here with full force. A treatment that genuinely stimulates biological repair and produces durable clinical improvement belongs in a different category from one that borrows the language of regeneration to market an ingredient with thin evidence.
Is regenerative medicine genuinely the future of aesthetic treatment?
Yes, but selectively. The underlying concept of stimulating the body's own biological processes to repair and renew tissue is scientifically sound and represents a genuinely important direction for aesthetic medicine. Some treatments currently operating under this banner are delivering on that promise with credible evidence behind them.
At the Cosmetic Doctors Company we are particularly impressed by Sculptra’s ability to stimulate collagen. Read more about why Sculptra is finally having its moment.
But the label has also attracted treatments whose connection to genuine biological regeneration is more marketing than mechanism. The future of aesthetic medicine almost certainly involves regenerative approaches — built on treatments that can demonstrate real, reproducible, independently verified clinical outcomes.
The honest answer to the question in our title is therefore: both. Regenerative medicine is genuinely the future — and some of what is currently being sold under that name is also the latest trend. Knowing the difference is the most clinically useful skill available to both practitioners and patients.
To find out more about our approach to aesthetic treatment, or to arrange a consultation, please visit our contact page or get in touch using the email or telephone links below.